An anti-cancer pill from Merck & Co can fight tumors and is safe in combination with palliative radiotherapy for patients with advanced pelvic cancer, data from early stage trials showed on Wednesday. The drug, called vorinostat and sold in the United States under the name Zolinza, is a new type of therapy called a histone [...]
Continue reading...
Wednesday, April 7, 2010
0 Comments